glp-1 news today obesity drug updates Pharmacy Pricing Update (Dec 2025) Dozens of new obesity drugs

Reassurance: Youre Not a Problem Patient Many patients feel embarrassed or worry they will be judged for using a weight-loss injection

Th1/Th17 cell is a T cell subset which co-expresses IFN- and IL-17A (47), driven by IL-12 or IL-23 (47, 48)

The data presented here support further evaluation of exenatide in a large randomized controlled trial, powered to evaluate clinically relevant outcome measures

The blend totals 2 billion AFU and contains: Akkermansia muciniphila Clostridium butyricum Clostridium beijerinckii Anaerobutyricum hallii Bifidobacterium infantis It also includes chicory inulin and oligofructose, prebiotics that act as "food" for probiotics

[Lincoff SELECT, NEJM 2023] FLOW Trial (NEJM 2024)

Because they're: Backed by clinical science Needle-free, non-invasive Rooted in functional medicine principles Affordable compared to Ozempic and similar drugs Supportive of habit change, not dependency For many, BioTrust GLP-1 Elevate bridges the gap between "doing nothing" and "taking prescriptions." It aligns with 2025's food-as-medicine and metabolic health-first movement